The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...

Zepbound, a drug used to help patients lose weight and manage diabetes, may also help those with heart failure, a new trial ...

Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

Let's consider just three: First, the company's tirzepatide -- sold under the brand name Mounjaro for diabetes and Zepbound ...

Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...

Drug manufacturers are racing to develop an oral version of popular weight loss injectables like Ozempic, and early studies ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...

As GLP-1 medications like Ozempic soar in popularity, our new documentary follows three people on their weight-loss journeys — and explores how decades of diet culture paved the way for the drugs’ ...

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly blockbuster GLP-1 drugs Zepbound and Mounjaro are in shortage. Shares of the ...